Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

ClinicalTrials.gov ID: NCT03518073

Public ClinicalTrials.gov record NCT03518073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Assessment of Safety, Tolerability, and Efficacy of LY3303560 in Early Symptomatic Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).

Study identification

NCT ID
NCT03518073
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
60 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2018 (Actual)
Primary completion
Aug 23, 2021 (Actual)
Completion
Oct 25, 2021 (Actual)
Last update posted
Aug 30, 2022

2018 – 2021

United States locations

U.S. sites
49
U.S. states
19
U.S. cities
48
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006 —
Center for Neurosciences Tucson Arizona 85718 —
Pharmacology Research Institute Encino California 91316 —
Fullerton Neurology and Headache Center Fullerton California 92835 —
Irvine Clinical Research Center Irvine California 92614 —
Pharmacology Research Institute Los Alamitos California 90720 —
National Research Institute - Huntington Park Panorama City California 91402 —
Anderson Clinical Research Redlands California 92374 —
Pacific Research Network San Diego California 92103 —
Univ of California San Francisco San Francisco California 94158 —
Syrentis Clinical Research Santa Ana California 92705 —
New England Institute for Clinical Research Stamford Connecticut 06905 —
JEM Research Institute Atlantis Florida 33462 —
Julie B. Schwartzbard, MD, PA Aventura Florida 33180 —
Quantum Laboratories Clinical Research Deerfield Beach Florida 33064 —
Brain Matters Research Delray Beach Florida 33445 —
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912 —
Infinity Clinical Research, LLC Hollywood Florida 33024 —
VIN-Victor Faradji Miami Florida 33176 —
Renstar Medical Research Ocala Florida 34470 —
BioClinica Inc Orlando Florida 32806 —
Progressive Medical Research Port Orange Florida 32127 —
Brain Matters Research Stuart Florida 34997 —
Infinity Clinical Research, LLC Sunrise Florida 33351 —
Columbus Memory Center, PC Columbus Georgia 31909 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
AMITA Health - Alexian Brothers Neurosciences Institute Clinical Research Elk Grove Village Illinois 60007 —
Josephson Wallack Munshower Neurology, PC Indianapolis Indiana 46256 —
Rowe Neurology Institute Lenexa Kansas 66214 —
Cotton O'Neil Clinic Topeka Kansas 66606 —
Pharmasite Research, Inc. Baltimore Maryland 21208 —
Tufts Medical Center Boston Massachusetts 02111 —
Boston Center for Memory Newton Massachusetts 02459 —
Clinical Research Professionals Chesterfield Missouri 63005 —
The Cognitive and Research Center of New Jersey Springfield New Jersey 07081 —
Advanced Memory Research Institute of New Jersey Toms River New Jersey 08755 —
Raleigh Neurology Associates, P.A. Raleigh North Carolina 27607 —
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103 —
Lindner Research Center Cincinnati Ohio 45219 —
Ohio State University Medical Center Columbus Ohio 43210 —
University of Cincinnati Health Neurology Dayton Ohio 45417 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18104 —
Suburban Research Associates Media Pennsylvania 19063 —
Butler Hospital Providence Rhode Island 02906 —
Baylor AT&T Memory Center Dallas Texas 75231 —
Neurology Consultants of Dallas, PA Dallas Texas 75243 —
Houston Methodist Research Ins Houston Texas 77030 —
The Memory Clinic Bennington Vermont 05201 —
Cognition Health Fairfax Virginia 22031 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03518073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03518073 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →